clinical trial · NCT06656351
B-FREE Chronic Babesiosis Study
Chronic BabesiosisTafenoquine 100mg
brief summary
Phase 2 Open Label Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue
started
Nov 18, 2025
primary completion
Feb 1, 2027
completion
Sep 1, 2027
last updated
Nov 21, 2025
official title
B-FREE Chronic Babesiosis Study: A Phase 2 Open Label Study of Tafenoquine for Treatment of Chronic Babesiosis Patients With Severe Fatigue
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol